Small- and medium-sized firms advised to develop their own R&D strategies

Business sources say that except for a small number of large pharmaceutical firms, about 400 small- and medium-sized firms in Korea are facing fierce competition among makers with excessive number of me-too products but without profit-making ones, and this has resulted in slashing their operating profits in the short term and the subsequent loss of competitiveness in the overseas markets strugg...